Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous sulfate + folic acid vs ferrous succinate for pregnancy iron deficiency anemia
ChiCTR2500105898Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferrous sulfate + folic acid and ferrous succinate in iron deficiency anemia (IDA) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Hemoglobin level (Hb) at week 12. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ferrous sulfate + folic acidferrous succinate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2500105898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105898.